Systemic retinoid (Vitamin A derivative) / Anti-acne
Pregnancy: ABSOLUTELY CONTRAINDICATED. Category X. Causes major malformations in virtually all fetuses.
Isotretinoin
Brand names: Roaccutane, Rizuderm
Adult dose
Dose: 0.5 mg/kg/day initially; usual range 0.5–1 mg/kg/day; cumulative dose target 120–150 mg/kg
Route: Oral (with food — improves absorption)
Frequency: Once or twice daily
Max: 1 mg/kg/day (standard); up to 2 mg/kg/day in severe recalcitrant cases
Start 0.5 mg/kg/day for 4 weeks. If no significant side effects, may increase to 1 mg/kg/day. Typical course 4–8 months to reach cumulative target of 120–150 mg/kg (minimum 4 months). Acne may flare initially.
Paediatric dose
Dose: 0.5 mg/kg
Route: Oral
Frequency: Once daily
Max: 1 mg/kg/day
≥12 years (licensed): same weight-based dosing as adults. Cumulative dose 120–150 mg/kg applies equally. Regular monitoring as for adults. Tetracyclines contraindicated in <12 years (avoid prescribing concurrently regardless of age).
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Avoid in severe hepatic impairment; monitor LFTs.
Paediatric weight-based calculator
≥12 years (licensed): same weight-based dosing as adults. Cumulative dose 120–150 mg/kg applies equally. Regular monitoring as for adults. Tetracyclines contraindicated in <12 years (avoid prescribing concurrently regardless of age).
Clinical pearls
- Pregnancy Prevention Programme: pregnancy test before, monthly during, 5 weeks after; 2 forms of contraception
- Not prescribable without REMS/PGP compliance (GPP/Pregnancy Prevention Programme in UK)
- Initial acne flare common (weeks 1–4) — advise patient
- Depression monitoring: NICE recommends asking about mood at each visit
- Avoid waxing, dermabrasion, laser while on isotretinoin (skin fragile — delayed healing)
Contraindications
- Pregnancy (Category X — extremely teratogenic)
- Women of childbearing potential without Pregnancy Prevention Programme compliance
- Breastfeeding
- Vitamin A supplementation
- Tetracycline co-prescription (raised ICP risk)
- Severe hyperlipidaemia
Side effects
- Dry skin, lips, mucous membranes (universal — manage with emollients)
- Teratogenicity (major — must not become pregnant during or 1 month after)
- Depression and suicidality (contested — monitor)
- Myalgia and arthralgia
- Elevated triglycerides and LDL
- Elevated LFTs
- Photosensitivity
- Night blindness
- Pseudotumor cerebri (especially with tetracyclines)
Interactions
- Tetracyclines — contraindicated (raised intracranial pressure)
- Vitamin A supplements — avoid (additive toxicity)
- Progestin-only contraceptives — reduced efficacy (use 2 methods)
- St John's Wort — may reduce contraceptive pill efficacy
Monitoring
- Pregnancy tests (monthly)
- Fasting lipids
- LFTs
- FBC
- Mood assessment
Reference: BNFc; BNF; MHRA Retinoid PPP; BAD Acne Guidelines; NICE CG184. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Acne Severity Classification (IGA Scale) · Acne
- SIRS Criteria and Sepsis Definition · Sepsis
- Revised Original International Autoimmune Hepatitis Score (IAIHG) · Autoimmune Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Rh(D) Immune Globulin Dosage for Maternal-Fetal Haemorrhage · Haematology in Pregnancy
- AREDS Classification of Age-related Macular Degeneration · Macular Degeneration
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD